Published in Proc Natl Acad Sci U S A on November 01, 1991
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev (2001) 4.68
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet (2006) 4.23
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol (2002) 2.65
Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA (2008) 2.30
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene (2007) 1.97
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci U S A (2004) 1.55
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43
Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int (2004) 1.31
Spinal deformity in neurofibromatosis type-1: diagnosis and treatment. Eur Spine J (2005) 1.30
Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol (2001) 1.30
Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins. Neuron (2010) 1.12
Age-related findings on MRI in neurofibromatosis type 1. Pediatr Radiol (2006) 1.01
Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase. Mol Carcinog (2009) 0.99
Mouse models of neurofibromatosis 1 and 2. Neoplasia (2002) 0.98
Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk. Brain Pathol (2009) 0.97
Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development (1995) 0.97
Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. Mol Cell Biol (2005) 0.90
4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res (2013) 0.89
Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. Am J Pathol (1999) 0.88
Clinical and genetic patterns of neurofibromatosis 1 and 2. Br J Ophthalmol (1993) 0.87
Disturbed osteoblastic differentiation of fibrous hamartoma cell from congenital pseudarthrosis of the tibia associated with neurofibromatosis type I. Clin Orthop Surg (2011) 0.87
Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs. Sarcoma (2008) 0.86
Neurofibromatosis and systemic lupus erythematosus. A matter of coincidence? Clin Rheumatol (2003) 0.86
The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells. Neuro Oncol (2012) 0.84
Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report. BMC Cancer (2005) 0.84
Differential regulation of cellular activities by GTPase-activating protein and NF1. Mol Cell Biol (1993) 0.83
Motor learning in children with neurofibromatosis type I. Cerebellum (2011) 0.82
Altered calcium-mediated cell signaling in keratinocytes cultured from patients with neurofibromatosis type 1. Am J Pathol (2002) 0.82
Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci Rep (2012) 0.82
Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons. Mol Cell Biol (2014) 0.78
Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis. BMC Dermatol (2002) 0.78
Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell. Am J Pathol (1994) 0.76
In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome. Front Cell Neurosci (2015) 0.76
Increased wild-type N-ras activation by neurofibromin down-regulation increases human neuroblastoma stem cell malignancy. Genes Cancer (2011) 0.76
Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis. Stem Cells Int (2012) 0.75
Alphavirus production is inhibited in neurofibromin 1-deficient cells through activated RAS signalling. Virology (2008) 0.75
Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models. J Histochem Cytochem (2017) 0.75
[Hereditary tumor syndromes in neuropathology]. Pathologe (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol (1990) 61.47
Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27
ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell (1991) 9.54
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (1990) 8.91
The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell (1989) 8.60
A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell (1990) 8.10
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell (1990) 6.94
Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med (1988) 5.84
The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell (1990) 5.24
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell (1990) 4.84
The trk proto-oncogene encodes a receptor for nerve growth factor. Cell (1991) 4.54
High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature (1991) 4.44
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell (1990) 4.12
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57
The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell (1990) 3.56
Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev (1991) 3.46
S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell (1990) 3.09
Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature (1990) 2.28
Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature (1991) 2.11
Multipoint linkage analysis in neurofibromatosis type I: an international collaboration. Am J Hum Genet (1989) 2.04
ras and GAP--who's controlling whom? Cell (1990) 1.63
Neurofilament protein phosphorylation--where, when and why. Trends Neurosci (1988) 0.97
Chromatin structure in Alzheimer's disease: effect on 5' leader sequence for NF-L gene and role of aluminum. Prog Clin Biol Res (1989) 0.81
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res (1991) 9.56
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Directional cloning of DNA fragments at a large distance from an initial probe: a circularization method. Proc Natl Acad Sci U S A (1984) 7.38
The mammalian gene collection. Science (1999) 7.19
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet (1997) 5.58
The molecular genetics of human hemoglobin. Prog Nucleic Acid Res Mol Biol (1984) 5.50
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet (1999) 4.79
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42
Direct sequencing of enzymatically amplified human genomic DNA. Proc Natl Acad Sci U S A (1988) 4.41
TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell (1995) 4.34
Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet (1996) 4.19
Genetic discrimination and health insurance: an urgent need for reform. Science (1995) 4.08
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88
Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87
Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A (1997) 3.76
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70
Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes. Mol Cell Biol (1992) 3.57
A de novo Alu insertion results in neurofibromatosis type 1. Nature (1991) 3.29
Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell (1999) 3.16
Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science (1991) 3.12
The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet (1995) 3.05
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA (1997) 2.73
Positional cloning: let's not call it reverse anymore. Nat Genet (1992) 2.69
Strategies for mapping and cloning macroregions of mammalian genomes. Methods Enzymol (1987) 2.68
Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res (1990) 2.62
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A (2001) 2.57
Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA (1993) 2.51
Medicaid enrollment and health services access by Latino children in inner-city Los Angeles. JAMA (1997) 2.50
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet (1995) 2.42
Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A (1998) 2.39
A point mutation in the A gamma-globin gene promoter in Greek hereditary persistence of fetal haemoglobin. Nature (1985) 2.33
Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood (1995) 2.23
Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res (1998) 2.17
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet (1993) 2.10
Mutational analysis using oligonucleotide microarrays. J Med Genet (1999) 2.05
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03
Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques (1996) 2.02
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet (2000) 2.00
BRCA1--lots of mutations, lots of dilemmas. N Engl J Med (1996) 1.94
Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol (1996) 1.92
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet (1997) 1.90
Evolutionary sequence comparisons using high-density oligonucleotide arrays. Nat Genet (1998) 1.90
Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest (1994) 1.86
Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell (1996) 1.84
G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene. Proc Natl Acad Sci U S A (1984) 1.84
Fine-structure genetic mapping of human chromosomes using the polymerase chain reaction on single sperm: experimental design considerations. Am J Hum Genet (1989) 1.83
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res (1997) 1.82
Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med (1998) 1.81
Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology (1993) 1.79
Cold pressor test as a predictor of hypertension. Hypertension (1984) 1.77
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet (1997) 1.77
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet (1995) 1.75
Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol (1992) 1.74
Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA (1998) 1.73
Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum Mol Genet (1993) 1.71
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70
The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene (2001) 1.69
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet (1993) 1.67
Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol (1988) 1.63
Different joining region J elements of the murine kappa immunoglobulin light chain locus are used at markedly different frequencies. Proc Natl Acad Sci U S A (1984) 1.60
CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57
How is the Human Genome Project doing, and what have we learned so far? Proc Natl Acad Sci U S A (1995) 1.50
Direct construction of a chromosome-specific NotI linking library from flow-sorted chromosomes. Nucleic Acids Res (1989) 1.49
Out-of-hospital pleomorphic ventricular tachycardia and resuscitation: association with acute myocardial ischemia and infarction. Ann Emerg Med (1992) 1.46
Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis (2001) 1.46
Magnetic bead capture of expressed sequences encoded within large genomic segments. Nature (1993) 1.45
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet (1993) 1.45
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43
Genetics moves into the medical mainstream. JAMA (2001) 1.41
Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet (1987) 1.40
Physician payment reform: a survival manual for physicians. Mayo Clin Proc (1992) 1.40
The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci U S A (1997) 1.39
Physical mapping of the cystic fibrosis region by pulsed-field gel electrophoresis. Genomics (1988) 1.38
Routine emergency department use for sick care by children in the United States. Pediatrics (1996) 1.38
The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron (1993) 1.36
SacI RFLP in the human von Willebrand factor gene. Nucleic Acids Res (1987) 1.36
Approach to genotyping errors caused by nontemplated nucleotide addition by Taq DNA polymerase. Genome Res (1995) 1.33
Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci U S A (1997) 1.32
Infantile myofibromatosis. Evidence for an autosomal-dominant disorder. Am J Surg Pathol (1984) 1.32
Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res (1997) 1.31
Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J (1998) 1.30
Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet (1989) 1.29
Innovative approaches to educating medical students for practice in a changing health care environment: the National UME-21 Project. Acad Med (2001) 1.29
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res (1999) 1.29
Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res (2005) 1.28
Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A (1993) 1.28
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res (1997) 1.27
Preparing health professionals for the genetic revolution. JAMA (1997) 1.27
Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia (2011) 1.27
Physical mapping of a translocation breakpoint in neurofibromatosis. Science (1989) 1.27